110 related articles for article (PubMed ID: 8825120)
1. Strategies for the development of recombinant vaccines for the immunotherapy of breast cancer.
Schlom J; Kantor J; Abrams S; Tsang KY; Panicali D; Hamilton JM
Breast Cancer Res Treat; 1996; 38(1):27-39. PubMed ID: 8825120
[TBL] [Abstract][Full Text] [Related]
2. The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines.
Arlen P; Tsang KY; Marshall JL; Chen A; Steinberg SM; Poole D; Hand PH; Schlom J; Hamilton JM
Cancer Immunol Immunother; 2000 Dec; 49(10):517-29. PubMed ID: 11129322
[TBL] [Abstract][Full Text] [Related]
3. CEA vaccines.
Bhagat A; Lyerly HK; Morse MA; Hartman ZC
Hum Vaccin Immunother; 2023 Dec; 19(3):2291857. PubMed ID: 38087989
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of MUC-1/CEA/TRICOM poxviral-based vaccine in patients with metastatic breast and ovarian cancer.
Mohebtash M; Tsang KY; Madan RA; Huen NY; Poole DJ; Jochems C; Jones J; Ferrara T; Heery CR; Arlen PM; Steinberg SM; Pazdur M; Rauckhorst M; Jones EC; Dahut WL; Schlom J; Gulley JL
Clin Cancer Res; 2011 Nov; 17(22):7164-73. PubMed ID: 22068656
[TBL] [Abstract][Full Text] [Related]
5. The targeted delivery of interleukin-12 to the carcinoembryonic antigen increases the intratumoral density of NK and CD8
Puca E; Schmitt-Koopmann C; Furter M; Murer P; Probst P; Dihr M; Bajic D; Neri D
J Gastrointest Oncol; 2020 Aug; 11(4):803-811. PubMed ID: 32953162
[TBL] [Abstract][Full Text] [Related]
6. CDKN2a/p16INK4a mutations and lack of p19ARF involvement in familial melanoma kindreds.
Fargnoli MC; Chimenti S; Keller G; Soyer HP; Dal Pozzo V; Höfler H; Peris K
J Invest Dermatol; 1998 Dec; 111(6):1202-6. PubMed ID: 9856841
[TBL] [Abstract][Full Text] [Related]
7. Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target.
Kanter-Lewensohn L; Dricu A; Wang M; Wejde J; Kiessling R; Larsson O
Melanoma Res; 1998 Oct; 8(5):389-97. PubMed ID: 9835451
[TBL] [Abstract][Full Text] [Related]
8. Comparison of high dose rate, low dose rate, and high dose rate fractionated radiation for optimizing differences in radiosensitivities in vitro.
Wilkins RC; Ng CE; Raaphorst GP
Radiat Oncol Investig; 1998; 6(5):209-15. PubMed ID: 9822167
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of B16 melanoma cells exposed in vitro to long-term IFN-alpha treatment (B16alpha cells) as a tumor vaccine in mice.
Wu TY; Fleischmann WR
J Interferon Cytokine Res; 1998 Oct; 18(10):829-39. PubMed ID: 9809618
[TBL] [Abstract][Full Text] [Related]
10. Ovarian small cell tumors: an electron microscopic review.
Dickersin GR; Scully RE
Ultrastruct Pathol; 1998; 22(3):199-226. PubMed ID: 9793201
[TBL] [Abstract][Full Text] [Related]
11. Malignant melanoma of the nictitating membrane in a cat (Felis vulgaris).
Roels S; Ducatelle R
J Comp Pathol; 1998 Aug; 119(2):189-93. PubMed ID: 9749364
[TBL] [Abstract][Full Text] [Related]
12. Evaluation on serum 2'-5'oligoadenylate synthetase (2'-5'oligoAS) and beta 2 microglobulin (B2M) in patients with nodal metastases from cutaneous malignant melanoma treated with rIFN-alpha 2A.
Martinetti A; Seregni E; Belli F; Mazzocchi A; Agresti R; Cascinelli N; Greco M; Bombardieri E
Anticancer Res; 1998; 18(3B):2027-30. PubMed ID: 9677461
[TBL] [Abstract][Full Text] [Related]
13. Allogeneic cells vaccine increases disease-free survival in stage III melanoma patients. A non randomized phase II study.
Mordoh J; Kairiyama C; Bover L; Solarolo E
Medicina (B Aires); 1997; 57(4):421-7. PubMed ID: 9674264
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of hyperthermic isolated limb perfusion for extremity-confined recurrent melanoma.
Brobeil A; Berman C; Cruse CW; De Conti R; Cantor A; Lyman GH; Joseph E; Rapaport D; Wells K; Reintgen DS
Ann Surg Oncol; 1998 Jun; 5(4):376-83. PubMed ID: 9641461
[TBL] [Abstract][Full Text] [Related]
15. Production of a motility factor by a newly established lung adenocarcinoma cell line.
Klominek J; Robért KH; Bergh J; Hjerpe A; Gahrton G; Sundqvist KG
Anticancer Res; 1998; 18(2A):759-67. PubMed ID: 9615717
[TBL] [Abstract][Full Text] [Related]
16. Colon adenocarcinoma and B-16 melanoma grow larger following laparotomy vs. pneumoperitoneum in a murine model.
Southall JC; Lee SW; Allendorf JD; Bessler M; Whelan RL
Dis Colon Rectum; 1998 May; 41(5):564-9. PubMed ID: 9593237
[TBL] [Abstract][Full Text] [Related]
17. MUC18, a member of the immunoglobulin superfamily, is expressed on bone marrow fibroblasts and a subset of hematological malignancies.
Filshie RJ; Zannettino AC; Makrynikola V; Gronthos S; Henniker AJ; Bendall LJ; Gottlieb DJ; Simmons PJ; Bradstock KF
Leukemia; 1998 Mar; 12(3):414-21. PubMed ID: 9529137
[TBL] [Abstract][Full Text] [Related]
18. The role of interleukin-2, interleukin-12, and dendritic cells in cancer therapy.
Lotze MT; Hellerstedt B; Stolinski L; Tueting T; Wilson C; Kinzler D; Vu H; Rubin JT; Storkus W; Tahara H; Elder E; Whiteside T
Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S109-14. PubMed ID: 9457405
[TBL] [Abstract][Full Text] [Related]
19. Conjunctival amelanotic malignant melanoma arising in primary acquired melanosis sine pigmento.
Jay V; Font RL
Ophthalmology; 1998 Jan; 105(1):191-4. PubMed ID: 9442798
[TBL] [Abstract][Full Text] [Related]
20. Recurrent melanoma of the leg and polypoid lesions of the gallbladder--a management dilemma.
Gould SW; Banwell PE; Rosin RD
Eur J Surg Oncol; 1997 Aug; 23(4):368-9. PubMed ID: 9315071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
